Submit a Manuscript to the Journal
Pharmaceutical Biology
For an Article Collection on
Alzheimer's Disease: From Pharmaceutical to Therapeutic Perspectives
Manuscript deadline
Article collection guest advisor(s)
Prof. James D. Adams,
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, USA
jadams@usc.edu
Prof. Demetrius M. Maraganore,
Department of Neurology, School of Medcine, Tulane University, New Orleans, LA 70112 USA
dmaraganore@tulane.edu
Prof. Linda Larson-Prior,
Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, United States
LJLarsonprior@uams.edu
Alzheimer's Disease: From Pharmaceutical to Therapeutic Perspectives
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia. It is characterized by memory loss and cognitive decline that may involve brain abnormalities like amyloid plaques and neurofibrillary tangles. The exact cause is unknown, but may include genetic, dietary and lifestyle changes with aging. Diagnosing AD involves medical evaluations and imaging. Currently, there is no cure, but treatments can manage symptoms and slow progression. With an aging population, AD poses significant health and social challenges.
This collection aims to explore the potential of natural compounds in preventing, managing, and treating AD, a neurodegenerative condition with significant global health implications.
The Article Collection welcomes submissions across a wide range of topics, including but not limited to:
- The therapeutic potential of natural products in AD management.
- Phytochemicals and their effects on AD pathology, including cognitive function and neuroprotection.
- Ethnopharmacological studies and traditional medicine practices related to AD.
- Preclinical and clinical investigations on natural product-derived AD therapies.
- Safety, efficacy, and pharmacokinetic profiles of natural products in AD treatment.
We welcome research articles, reviews, perspectives, short communications, data note, and methods.
Disclosure statement: All Guest Advisors declare no conflict of interest.
All manuscripts submitted to this Article Collection will undergo desk assessment and peer review if they can pass the desk assessments as part of our standard editorial process; the Guest Advisor for this Collection will not be handling the manuscripts (unless they are an Editorial Board member).
Please review the journal scope and author submission instructions before submitting a manuscript.
The deadline for submitting manuscripts is 30 November 2025.
Please contact Catherine Teng at catherine.teng@taylorandfrancis.com with any queries and discount codes regarding this Article Collection.
Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.